CAMBRIDGE, Mass., May 08, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that management will participate in two upcoming investor conferences in May. Details are as follows:
Bank of America Merrill Lynch 2017 Health Care Conference
Date: | Wednesday, May 17, 2017 | ||
Forum: | Panel Discussion on Gene Therapy and Gene Editing | ||
Time: | 4:40 p.m. ET | ||
Location: | Las Vegas |
UBS Global Healthcare Conference
Date: | Monday, May 22, 2017 | ||
Forum: | Company Presentation and Breakout Session | ||
Time: | 8:00 a.m. ET | ||
Location: | New York |
A live webcast of the presentation will be available on the Investors & Media section of the Editas website at www.editasmedicine.com. An archived replay will be available for approximately 30 days following the presentation.
About Editas Medicine
Editas Medicine is a leading genome editing company dedicated to treating patients with genetically-defined diseases by correcting their disease-causing genes. The company was founded by world leaders in genome editing, and its mission is to translate the promise of genome editing science into a broad class of transformative genomic medicines to benefit the greatest number of patients.